Navigation Links
Par Pharmaceutical Companies to Report Third Quarter 2011 Results on November 2, 2011
Date:10/3/2011

WOODCLIFF LAKE, N.J., Oct. 3, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Wednesday, November 2, 2011 at 9:00 AM EDT to review results for the third quarter 2011. The Company will release its financial results on November 2, 2011 before the market opens.

Access to the live webcast can be made via the Company's website at www.parpharm.com.

Dial-in Information
Domestic: 800-901-5241
International: 617-786-2963
Passcode: 52087832

A replay of the conference call will be available for two weeks approximately one hour after the call.

Replay Information
Domestic: 888-286-8010
International: 617-801-6888
Passcode: 42213272

About Par

Par Pharmaceutical Companies, Inc. is a US-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. The Law Firm of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches of Fiduciary Duty by the Board of Pharmaceutical Product Development, Inc. in Connection With Sale of the Company to The Carlyle Group and Hellman & Friedman
2. OncoMed Pharmaceuticals Names Dr. Jakob Dupont VP Clinical Research
3. Optimer Pharmaceuticals to Present at BioCentury Newsmakers Conference
4. CoLucid Pharmaceuticals to Present at Sofinnova Japan Biopharma Partnering Conference on Tuesday, October 4th in Tokyo, Japan
5. Top 1000 Pharmaceutical Wholesalers (Global)
6. Top 1000 Pharmaceutical Manufacturers (Asian)
7. Top 450 Biotechnology (Pharmaceuticals) Report (Global)
8. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
9. McNEIL-PPC, Inc. Acquires Full Ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals Co. Joint Venture
10. K-V Pharmaceutical Company to Present at Imperial Capitals 5th Annual Global Opportunities Conference
11. Onyx Pharmaceuticals Submits New Drug Application for Carfilzomib in Relapsed and Refractory Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray product ... a healthy CAGR during the forecast period Mobile ... the global digital mobile X-Ray devices market, which is estimated ... 2017, expanding at a CAGR of 7% over the forecast ... opportunity of more than US$ 100 Mn in 2017 over ...
(Date:4/19/2017)... , April 19, 2017 The ... Application, Forecast to 2022 report has covered and analysed the ... and information on market size, shares and growth factors. The ... drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... , http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” ... Water, Global Climate Change and Your Health on Voice America sponsored by Nature’s ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... for the North East region. Côté has 20+ years of experience within the ... Phytomer, Côté worked with an array of high-end cosmetic brands, retail brands and ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies and ... the host of the “Informed” series. The program focuses on many important issues that ... on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, people ...
Breaking Medicine News(10 mins):